Regev Cohen

2.3k total citations · 2 hit papers
44 papers, 1.2k citations indexed

About

Regev Cohen is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Regev Cohen has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Regev Cohen's work include Antibiotic Resistance in Bacteria (10 papers), Viral Infections and Vectors (8 papers) and Vector-borne infectious diseases (7 papers). Regev Cohen is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Viral Infections and Vectors (8 papers) and Vector-borne infectious diseases (7 papers). Regev Cohen collaborates with scholars based in Israel and United States. Regev Cohen's co-authors include Talya Finn, Norbert Frickhofen, J. Michael Berry, Irene Halperín, L. King, David M. Mintzer, Janis L. Abkowitz, Monika M. Safford, Alan B. Astrow and Svetlana Paikin and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Regev Cohen

43 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

2021 224 citations Ayelet Grupper, Nechama Sharon et al. Clinical Journal of the American Society of Nephrology profile →
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

2021 199 citations Michal Chowers, Meital Elbaz et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Regev Cohen

Since Specialization

Citations

This map shows the geographic impact of Regev Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regev Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regev Cohen more than expected).

Fields of papers citing papers by Regev Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regev Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regev Cohen. The network helps show where Regev Cohen may publish in the future.

Co-authorship network of co-authors of Regev Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Regev Cohen. A scholar is included among the top collaborators of Regev Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regev Cohen. Regev Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An emergency department intervention to improve earlier detection of community-onset bloodstream infection among hospitalized patients 2024 ·American Journal of Infection Control ·Regev Cohen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sarit Freimann	1
2	Reassessing the need for scheduled replacement of short term central venous catheters: A narrative comprehensive review 2024 ·Infection Prevention in Practice ·Regev Cohen	0
3	Exposure to Non-Antimicrobial Drugs and Risk of Infection with Antibiotic-Resistant Enterobacteriaceae 2023 ·Antibiotics ·Meital Elbaz, (unknown), (unknown), Ahuva Weiss‐Meilik, Regev Cohen, Ronen Ben‐Ami	3
4	High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients 2021 ·Infectious Diseases ·Regev Cohen, Talya Finn, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Zvi Shimoni, Svetlana Paikin, (unknown), Jonathan Lellouche	22
5	Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis breakdown → 2021 ·Clinical Journal of the American Society of Nephrology ·Ayelet Grupper, Nechama Sharon, Talya Finn, Regev Cohen, (unknown), (unknown), (unknown), Idit F. Schwartz, Doron Schwartz, (unknown), Moshe Shashar	224
6	Epidemiological, clinical and laboratory features of acute Q fever in a cohort of hospitalized patients in a regional hospital, Israel, 2012-2018 2021 ·PLoS neglected tropical diseases ·Talya Finn, (unknown), (unknown), (unknown), Svetlana Paikin, Jonathan Lellouche, (unknown), Regev Cohen	7
7	Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Clinical Isolates during 7.5 Years in One Regional Hospital in Israel 2021 ·Journal of Environmental and Public Health ·Regev Cohen, Svetlana Paikin, Talya Finn, (unknown), (unknown), (unknown), Assaf Rokney	1
8	High Rates of Bacterial Pulmonary Co-Infections and Superinfections Identified by Multiplex PCR among Critically Ill COVID-19 Patients 2021 ·Microorganisms ·Regev Cohen, (unknown), Talya Finn, (unknown), (unknown), (unknown), (unknown), (unknown), Svetlana Paikin, Jonathan Lellouche	24
9	Multidrug-resistant enterobacteriaceae in coastal water: an emerging threat 2020 ·Antimicrobial Resistance and Infection Control ·Regev Cohen, Svetlana Paikin, Assaf Rokney, Maxim Rubin‐Blum, (unknown)	19
10	Investigation of Outbreaks of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae in Three Neonatal Intensive Care Units Using Whole Genome Sequencing 2020 ·Antibiotics ·Sammy Frenk, (unknown), Elizabeth Temkin, Vered Schechner, Regev Cohen, (unknown), Mitchell J. Schwaber, Ester Solter, (unknown), (unknown), Yehuda Carmeli	16
11	Disseminated “Haemophilus quentini” infection in a patient with multiple myeloma — a case report and review of the literature 2019 ·Diagnostic Microbiology and Infectious Disease ·Regev Cohen, Talya Finn, (unknown), (unknown), Svetlana Paikin, Amos Adler, Yuval Geffen, Assaf Rokney, M. Ron	3
12	Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus – A single center retrospective observational study 2019 ·PLoS ONE ·Regev Cohen, (unknown), (unknown), Talya Finn	35
13	Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases 2018 ·Travel Medicine and Infectious Disease ·(unknown), (unknown), Yaniv Lustig, Zohar Mor, (unknown), Michal Chowers, Shlomo Maayan, Oren Zimhony, Ronen Ben‐Ami, Bibiana Chazan, (unknown), Regev Cohen, (unknown), Rivka Sheffer, Emilia Anis, Yael Glazer, (unknown), Ella Mendelson, Eyal Leshem	14
14	Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study 2017 ·Diagnostic Microbiology and Infectious Disease ·(unknown), (unknown), Talya Finn, Zvi Shimoni, (unknown), Ronen Ben‐Ami, Regev Cohen	9
15	Treatment of febrile geriatric patients with suspected urinary tract infections in a hospital with high rates of ESBL producing bacteria: a cohort study 2016 ·BMJ Open ·Zvi Shimoni, Regev Cohen, (unknown), Paul Froom	11
16	Water faucets as a source of Pseudomonas aeruginosa infection and colonization in neonatal and adult intensive care unit patients 2016 ·American Journal of Infection Control ·Regev Cohen, (unknown), Zvi Shimoni, (unknown), (unknown), (unknown), Amos Adler, Svetlana Paikin	14
17	Effect of a ventilator-focused intervention on the rate of Acinetobacter baumannii infection among ventilated patients 2014 ·American Journal of Infection Control ·Regev Cohen, Zvi Shimoni, (unknown), Ron Ram, Ronen Ben‐Ami	4
18	A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel 2014 ·Clinical Microbiology and Infection ·Amos Adler, (unknown), Marc V. Assous, Yuval Geffen, Svetlana Paikin, David A. Schwartz, (unknown), Khetam Hussein, Regev Cohen, Yehuda Carmeli	18
19	Postexposure Treatment with Doxycycline for the Prevention of Tick-Borne Relapsing Fever 2006 ·New England Journal of Medicine ·Tal Hasin, Nadav Davidovitch, Regev Cohen, (unknown), Ayal Romem, Nadav Orr, Eyal Klement, Nir Lubezky, Raid Kayouf, Tamar Sela, Nathan Keller, Estela Derazne, Tamar Halperin, Miri Yavzori, Itamar Grotto, Dani Cohen	32
20	Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene 2006 ·Acta Tropica ·Tamar Halperin, Nadav Orr, Regev Cohen, Tal Hasin, Nadav Davidovitch, Eyal Klement, Raid Kayouf, Gad Baneth, Dani Cohen, Miri Yavzori	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact